An Experimental Study on Prevention of Cerebral Vasospasm with Lidocaine Injection in A Rabbit Model Ofsubarachnoid Hemorrhage

SHI Xian-qing,SI Yong-yu,YIN Miao-miao,CHEN Yan-fang,LIU Jin
DOI: https://doi.org/10.3969/j.issn.1000-2707.2006.02.004
2006-01-01
Abstract:Objective: To investigate the prevention of cerebral vasospasm by injecting lidocaine into cisterna magna of a rabbit model of subarachnoid hemorrhage(SAH).Methods: Thirty New Zealand white rabbits are randomized to control group(A),subarachnoid hemorrhage group(B),and lidocaine therapy group(C).There were ten animals in each group.The animals of groups B and C were injected with 1.5 ml of nonheparinized autologous arterial blood into cisterna magna as mimic SAH,while those in group A received 1.5 ml saline into cisterna magna instead. In thirty minutes after SAH,the animals in group A and group B were injected with 0.1 ml of saline into cisterna magna,while 0.1 ml of 2% lidocaine were injected into cisterna magna of rabbits in group C.The animals were killed in 72 hours after SAH and their basilar arteries were prepared for morphometric analysis.The blood contents of endothelin(ET) and calcitonin gene-related peptide(CGRP) were determined before and 72 hours after SAH.Results: The preoperative blood contents of ET and CGRP were not significantly different in all of the animals.The blood contents of ET of 3 groups after SAH were higher than those before operation(P0.01 or P0.001).The content of ET in B group was higher than those of groups A and C after SAH(P0.05).The contents of CGRP were not significantly different among groups after SAH(P0.05),but were lower than those before operation(P0.01 or P0.001).The cross-section areas of basal arteries were smaller in B group than those of the other two groups(P0.001).Conclusions: The study results prove that lidocaine injection in cisterna magna can prevent the cerebral vasospasm in rabbit model of subarachnoid hemorrhage.
What problem does this paper attempt to address?